Screening of Anticancer Drugs Against Potential
An in silico study exploring interactions between clinically used anticancer drugs...
Read More →AI-ENZO, our flagship AI agent for biomedical discovery, recognized among the top 35 global innovations driving real-world impact through AI.
Learn More →The Journal of Pharmacology and Experimental Therapeutics
An in silico study exploring interactions between clinically used anticancer drugs and bacterial virulence proteins associated with colorectal cancer.
Read More →Molecular and Biochemical Parasitology
Computational analysis of mutation-driven changes in antimalarial drug interactions using molecular docking and molecular dynamics simulations.
Read More →Molecular Biology Reports
An integrated in vitro and in silico study investigating AiiA lactonase activity against H. pylori biofilm formation and associated virulence factors.
Read More →Journal of Biomolecular Structure and Dynamics
In silico validation of hyaluronic acid–drug conjugates targeting key SARS-CoV-2 proteins for potential cell-targeted drug delivery.
Read More →An in silico study exploring interactions between clinically used anticancer drugs...
Read More →An in silico study exploring interactions between clinically used anticancer drugs...
Read More →An in silico study exploring interactions between clinically used anticancer drugs...
Read More →An in silico study exploring interactions between clinically used anticancer drugs...
Read More →
Enhanced enzyme function prediction with 18% higher accuracy and improved.
MAY 12, 2024
New deep learning model for protein-ligand binding affinity prediction.
APR 30, 2024
Integrated platform for multi-omics visualization and downstream analysis.
APR 15, 2024
High-performance cloud infrastructure for large-scale bioinformatics analysis.
MAR 28, 2024
Join NyBerMan as a Research Expert or Collaborator and partner on cutting-edge research, co-create solutions and drive meaningful scientific discoveries.
